JP2024517855A5 - - Google Patents
Info
- Publication number
- JP2024517855A5 JP2024517855A5 JP2023568204A JP2023568204A JP2024517855A5 JP 2024517855 A5 JP2024517855 A5 JP 2024517855A5 JP 2023568204 A JP2023568204 A JP 2023568204A JP 2023568204 A JP2023568204 A JP 2023568204A JP 2024517855 A5 JP2024517855 A5 JP 2024517855A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion polypeptide
- amino acid
- metal hydroxide
- seq
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163184620P | 2021-05-05 | 2021-05-05 | |
| US63/184,620 | 2021-05-05 | ||
| PCT/US2022/027617 WO2022235755A2 (en) | 2021-05-05 | 2022-05-04 | Fusion polypeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517855A JP2024517855A (ja) | 2024-04-23 |
| JP2024517855A5 true JP2024517855A5 (enExample) | 2025-05-15 |
Family
ID=82020825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568204A Pending JP2024517855A (ja) | 2021-05-05 | 2022-05-04 | 融合ポリペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US12454695B2 (enExample) |
| EP (1) | EP4334337A2 (enExample) |
| JP (1) | JP2024517855A (enExample) |
| KR (1) | KR20240028341A (enExample) |
| AU (1) | AU2022269602A1 (enExample) |
| CA (1) | CA3217079A1 (enExample) |
| IL (1) | IL308240A (enExample) |
| WO (1) | WO2022235755A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12454695B2 (en) | 2021-05-05 | 2025-10-28 | Ankyra Therapeutics, Inc. | Fusion polypeptides comprising interleukin 12 and a metal-hydroxide binding polypeptide |
| IL312221A (en) | 2021-10-20 | 2024-06-01 | Synthekine Inc | Heterodimeric fc cytokines and uses thereof |
| EP4615976A2 (en) * | 2022-11-09 | 2025-09-17 | Ankyra Therapeutics, Inc. | Methods of making fusion polypeptides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202100935TA (en) | 2018-09-28 | 2021-02-25 | Massachusetts Inst Technology | Collagen-localized immunomodulatory molecules and methods thereof |
| JP2022538974A (ja) | 2019-06-26 | 2022-09-07 | マサチューセッツ インスチテュート オブ テクノロジー | 免疫調節融合タンパク質－金属水酸化物錯体およびその方法 |
| US12454695B2 (en) | 2021-05-05 | 2025-10-28 | Ankyra Therapeutics, Inc. | Fusion polypeptides comprising interleukin 12 and a metal-hydroxide binding polypeptide |
-
2022
- 2022-05-04 US US17/736,431 patent/US12454695B2/en active Active
- 2022-05-04 JP JP2023568204A patent/JP2024517855A/ja active Pending
- 2022-05-04 CA CA3217079A patent/CA3217079A1/en active Pending
- 2022-05-04 KR KR1020237041893A patent/KR20240028341A/ko active Pending
- 2022-05-04 IL IL308240A patent/IL308240A/en unknown
- 2022-05-04 WO PCT/US2022/027617 patent/WO2022235755A2/en not_active Ceased
- 2022-05-04 EP EP22730331.0A patent/EP4334337A2/en active Pending
- 2022-05-04 AU AU2022269602A patent/AU2022269602A1/en active Pending
-
2025
- 2025-06-26 US US19/251,378 patent/US20250327085A1/en active Pending
- 2025-10-08 US US19/352,767 patent/US20260035706A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230321109A1 (en) | Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses | |
| JP4303595B2 (ja) | アニオン性置換基を有する物質を捕捉可能な亜鉛錯体 | |
| JP2022115876A5 (enExample) | ||
| Walton et al. | Branched-chain sugar nucleosides. V. Synthesis and antiviral properties of several branched-chain sugar nucleosides | |
| JP2021527042A (ja) | 腫瘍微小環境活性化薬物・結合剤コンジュゲート、及びそれに関連する使用 | |
| JP2002513795A (ja) | モノマー、オリゴマーおよびポリマーのクネベナーゲル縮合生成物 | |
| Zimmermann et al. | RNA-protein interactions in the ribosome: II. Binding of ribosomal proteins to isolated fragments of the 16 S RNA | |
| JP2015518705A (ja) | ヒト疾患に関連する生物製剤およびタンパク質の産生のための修飾ポリヌクレオチド | |
| JP2018531287A5 (enExample) | ||
| RU2017135552A (ru) | Глутамат оксалоацетат трансаминаза 1 (got1), препараты и способы их получения и применения | |
| CN119019514A (zh) | 一种具有免疫原性的呼吸道合胞病毒（rsv）多肽 | |
| CN112409450B (zh) | TIGIT-IgV的亲和剂及其应用 | |
| KR102018774B1 (ko) | Glypican-3에 선택적으로 결합하는 압타머 및 이의 용도 | |
| JP2022537052A (ja) | 操作された腫瘍選択的タンパク質発現 | |
| JP2022528053A5 (enExample) | ||
| ATE266731T1 (de) | Neue menschliche proteine, die cyclin abhängigen kinasen ähneln, sowie methoden zu deren verwendung | |
| KR101680335B1 (ko) | 상피세포 성장인자 수용체 압타머 및 이를 포함하는 항암제 조성물 | |
| CN107266552B (zh) | 源自于prame的肿瘤抗原短肽 | |
| CN117417456A (zh) | 一种多价Fab结合肽及其制备和应用 | |
| CN117624371A (zh) | 一种新型的抗体药物偶联物制备方法 | |
| CN108250289B (zh) | 源自于mage b6的肿瘤抗原短肽 | |
| CA2356189A1 (en) | Substance for obtaining highly effective tumor medications as well as a process | |
| KR20030077950A (ko) | 생리활성 복합체 | |
| US7892834B2 (en) | Cellular signal-responsive gene transcriptional regulation system | |
| US20250179186A1 (en) | Anti-b7-h3 compounds and methods of use |